Adam Simons, MD
Internal Medicine · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 17 years
- University of California, Davis School of Medicine, 2009
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Simons’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A127652 · Current
Licensed to practise in California · since 2013 · expires 2027-01-31 · University of California, Davis School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$123,176
Medicare paid this office $123,176 for 315 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 202 | $86,755 | $103 |
| Hospital discharge day management, more than 30 minutes | 170 | $18,281 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $16,462 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,275 | $116 |
Who their Medicare patients are
315 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 10% · Women 45% · Also on Medicaid 31% · Health risk score 2.54. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 54% · Chronic kidney disease 50% · Atrial fibrillation 49% · Diabetes 45% · Heart failure 43% · Depression 33% · Cancer 26% · COPD 25% · Dementia 13% · Stroke 13%.
The office billed $456,528, Medicare allowed $156,593 and paid $123,176; for 1,140 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 315 | 1,140 | 73 | 2.54 | $456,528 | $123,176 |
| 2023 | 253 | 781 | 72 | 2.70 | $313,591 | $86,315 |
| 2022 | 272 | 771 | 73 | 2.20 | $313,773 | $80,184 |
| 2021 | 301 | 831 | 72 | 2.60 | $319,125 | $85,124 |
| 2020 | 270 | 731 | 72 | 2.64 | $322,021 | $76,788 |
| 2019 | 280 | 856 | 69 | 2.96 | $365,475 | $84,751 |
| 2018 | 274 | 893 | 70 | 2.68 | $371,115 | $86,716 |
| 2017 | 239 | 760 | 68 | 2.74 | $319,470 | $75,116 |
| 2016 | 285 | 960 | 69 | 2.78 | $407,691 | $96,597 |
| 2015 | 263 | 809 | 69 | 2.90 | $343,121 | $80,930 |
| 2014 | 254 | 828 | 68 | 2.19 | $349,092 | $81,319 |
| 2013 | 140 | 148 | 66 | 2.79 | $53,346 | $19,679 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $60,890 | $106 |
| Hospital discharge day management, more than 30 minutes | 120 | $12,939 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $11,116 | $154 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 153 | $46,671 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $15,800 | $176 |
| Hospital discharge day management, more than 30 minutes | 97 | $9,792 | $95 |
| Initial hospital observation care per day, typically 70 minutes | 29 | $4,371 | $151 |
| Hospital observation care on day of discharge | 20 | $1,208 | $60 |
2021: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 179 | $50,333 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $13,049 | $179 |
| Hospital discharge day management, more than 30 minutes | 119 | $12,662 | $97 |
| Initial hospital observation care per day, typically 70 minutes | 19 | $2,952 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,961 | $123 |
| Hospital observation care on day of discharge | 28 | $1,791 | $64 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,331 | $121 |
2020: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 158 | $46,892 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,630 | $186 |
| Hospital discharge day management, more than 30 minutes | 101 | $10,478 | $100 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,215 | $170 |
| Hospital observation care on day of discharge | 28 | $1,868 | $67 |
2019: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 189 | $57,684 | $93 |
| Hospital discharge day management, more than 30 minutes | 123 | $13,448 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $8,240 | $179 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,224 | $111 |
| Hospital observation care on day of discharge | 18 | $1,206 | $67 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 205 | $61,217 | $91 |
| Hospital discharge day management, more than 30 minutes | 127 | $13,319 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,424 | $175 |
| Hospital observation care on day of discharge | 14 | $793 | $57 |
2017: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 176 | $52,882 | $93 |
| Hospital discharge day management, more than 30 minutes | 109 | $11,172 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,875 | $176 |
| Hospital observation care on day of discharge | 12 | $795 | $66 |
2016: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 198 | $64,012 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,182 | $181 |
| Hospital discharge day management, more than 30 minutes | 123 | $12,943 | $97 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,161 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,164 | $65 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $55,664 | $93 |
| Hospital discharge day management, more than 30 minutes | 112 | $11,535 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $9,889 | $180 |
| Hospital observation care on day of discharge | 13 | $759 | $58 |
2014: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 194 | $55,031 | $93 |
| Hospital discharge day management, more than 30 minutes | 106 | $10,975 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $7,467 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,158 | $64 |
| Hospital observation care on day of discharge | 11 | $788 | $66 |
2013: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $10,846 | $159 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $5,444 | $111 |
Medicaid work
$23,622 in 2024
Medicaid paid $23,622 for 486 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 458 | $21,906 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 28 | $1,715 |
| 2024 | 486 | 2 | 24 | $23,622 |
| 2023 | 363 | 3 | 20 | $19,187 |
| 2022 | 285 | 2 | 20 | $14,897 |
| 2021 | 217 | 1 | 17 | $11,058 |
| 2020 | 281 | 3 | 22 | $12,826 |
| 2019 | 135 | 2 | 15 | $7,549 |
| 2018 | 223 | 1 | 20 | $10,929 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 321 | $15,919 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $1,751 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 27 | $1,517 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 270 | $13,658 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 15 | $1,239 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 217 | $11,058 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 252 | $11,321 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $972 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 16 | $532 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 121 | $6,815 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 14 | $734 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 223 | $10,929 |
Drugs they prescribed that Part D paid
$65,032
Pharmacies billed $65,032 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (45 of 405) in 2024. A higher opioid share than 9 in 10 peers; the typical internal medicine clinician is at 1%.
340 generic and fewer than 11 brand-name prescriptions · $65,032 in drug cost · 71 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 17 | $9,751 | $574 |
| Amiodarone | 17 | $411 | $24 |
| Oxycodone | 13 | $174 | $13 |
| Pantoprazole | 21 | $157 | $7 |
| Hydrocodone-Acetaminophen | 15 | $154 | $10 |
See all 11 drugs
| Eliquis | 17 | $9,751 | $574 |
| Amiodarone | 17 | $411 | $24 |
| Oxycodone | 13 | $174 | $13 |
| Pantoprazole | 21 | $157 | $7 |
| Hydrocodone-Acetaminophen | 15 | $154 | $10 |
| Ciprofloxacin | 21 | $90 | $4 |
| Potassium Chloride | 11 | $59 | $5 |
| Furosemide | 19 | $58 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $55 | $5 |
| Tramadol | 14 | $33 | $2 |
| Metoprolol | 11 | $22 | $2 |
Year by year
| 2024 | 405 | 137 | 11% (45) | None | $65,032 |
| 2023 | 192 | 88 | 14% (27) | 11% | $30,394 |
| 2022 | 286 | 110 | 12% (35) | 13% | $34,550 |
| 2021 | 437 | 117 | 6% (26) | None | $74,733 |
| 2020 | 375 | 100 | 4% (14) | None | $94,910 |
| 2019 | 424 | 109 | 7% (30) | 16% | $45,580 |
| 2018 | 454 | 101 | 6% (25) | None | $43,273 |
| 2017 | 396 | 90 | 9% (36) | None | $33,796 |
| 2016 | 491 | 112 | 10% (49) | None | $38,827 |
| 2015 | 298 | 78 | 6% (17) | None | $33,562 |
| 2014 | 206 | 70 | 13% (27) | None | $23,869 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ciprofloxacin | 13 | $129 | $10 |
| Pantoprazole | 12 | $118 | $10 |
| Furosemide | 14 | $102 | $7 |
2022: 5 drugs
| Pantoprazole | 21 | $201 | $10 |
| Hydrocodone-Acetaminophen | 13 | $113 | $9 |
| Ciprofloxacin | 12 | $73 | $6 |
| Metoprolol | 19 | $61 | $3 |
| Furosemide | 18 | $43 | $2 |
2021: 12 drugs
| Eliquis | 22 | $11,710 | $532 |
| Januvia | 12 | $7,945 | $662 |
| Valganciclovir | 15 | $2,200 | $147 |
| Lactulose | 11 | $488 | $44 |
| Pantoprazole | 32 | $374 | $12 |
| Ondansetron Odt | 11 | $173 | $16 |
| Pravastatin | 12 | $168 | $14 |
| Spironolactone | 11 | $109 | $10 |
| Sertraline | 13 | $91 | $7 |
| Ciprofloxacin | 14 | $79 | $6 |
| Hydrocodone-Acetaminophen | 11 | $62 | $6 |
| Furosemide | 20 | $59 | $3 |
2020: 8 drugs
| Xifaxan | 27 | $72,250 | $2,676 |
| Eliquis | 11 | $6,233 | $567 |
| Lactulose | 17 | $679 | $40 |
| Spironolactone | 27 | $642 | $24 |
| Furosemide | 41 | $234 | $6 |
| Atorvastatin | 13 | $158 | $12 |
| Pantoprazole | 18 | $139 | $8 |
| Ciprofloxacin | 21 | $129 | $6 |
2019: 8 drugs
| Xifaxan | 11 | $19,217 | $1,747 |
| Bumetanide | 23 | $1,914 | $83 |
| Spironolactone | 35 | $810 | $23 |
| Lactulose | 22 | $555 | $25 |
| Ciprofloxacin | 25 | $302 | $12 |
| Furosemide | 28 | $269 | $10 |
| Pantoprazole | 23 | $251 | $11 |
| Metoprolol | 12 | $172 | $14 |
2018: 12 drugs
| Ursodiol | 13 | $3,821 | $294 |
| Amiodarone | 14 | $1,095 | $78 |
| Atorvastatin | 20 | $267 | $13 |
| Pantoprazole | 23 | $188 | $8 |
| Potassium Chloride | 16 | $172 | $11 |
| Furosemide | 33 | $158 | $5 |
| Metoclopramide | 12 | $150 | $12 |
| Spironolactone | 11 | $137 | $12 |
| Lisinopril | 15 | $86 | $6 |
| Famotidine | 13 | $81 | $6 |
| Ciprofloxacin | 13 | $73 | $6 |
| Metoprolol | 18 | $72 | $4 |
2017: 9 drugs
| Clinisol | 23 | $5,629 | $245 |
| Polyethylene Glycol 3350 | 13 | $963 | $74 |
| Spironolactone | 14 | $259 | $19 |
| Pantoprazole | 19 | $227 | $12 |
| Tamsulosin | 12 | $139 | $12 |
| Ciprofloxacin | 19 | $112 | $6 |
| Hydrocodone-Acetaminophen | 12 | $88 | $7 |
| Furosemide | 20 | $62 | $3 |
| Metoprolol | 11 | $32 | $3 |
2016: 10 drugs
| Polyethylene Glycol 3350 | 23 | $983 | $43 |
| Lactulose | 13 | $342 | $26 |
| Pantoprazole | 32 | $286 | $9 |
| Hydrocodone-Acetaminophen | 21 | $280 | $13 |
| Spironolactone | 18 | $227 | $13 |
| Ciprofloxacin | 23 | $184 | $8 |
| Furosemide | 39 | $102 | $3 |
| Carvedilol | 11 | $69 | $6 |
| Amlodipine Besylate | 12 | $60 | $5 |
| Metoprolol | 16 | $52 | $3 |
2015: 5 drugs
| Pantoprazole | 34 | $522 | $15 |
| Spironolactone | 14 | $193 | $14 |
| Ciprofloxacin | 14 | $96 | $7 |
| Famotidine | 12 | $86 | $7 |
| Furosemide | 19 | $80 | $4 |
2014: 4 drugs
| Polyethylene Glycol 3350 | 13 | $545 | $42 |
| Pantoprazole | 19 | $204 | $11 |
| Hydrocodone-Acetaminophen | 14 | $175 | $13 |
| Ciprofloxacin | 15 | $100 | $7 |
Money from drug and device companies
$171 in 2025
A payment is not proof that care is biased.
| Biotronik Nro | Prospera | $171 | 1 payment
|
See the published payment
| Biotronik Nro | Meals · 2025-05-14 | Prospera | $171 |
Professional record
- NPI
- 1588892210
- Licence
- CA 127652California A127652: Current · expires 2027-01-31
- Trained
- University of California, Davis School of Medicine, 2009 · 17 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Hospitalist (208M00000X); Student in a training program (390200000X)
- Mailing address
- 2351 Clay St, Suite 308, San Francisco, CA, 94115
- NPI first listed
- 2009-07-01
- NPI last updated
- 2014-09-04
This is when the NPI record was last certified, not a medical board exam.